Literature DB >> 1394207

Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.

R Radinsky1, H Z Weisberg, A N Staroselsky, I J Fidler.   

Abstract

The purpose of this study was to determine whether nm23 steady-state mRNA expression levels correlate with metastatic potential of mouse K-1735 melanoma cells, human KM12 colon cancer cells, and human SN12 renal cancer cells. Since neoplasms are heterogeneous and contain subpopulations of cells with different metastatic potentials, we analyzed multiple sets of nonmetastatic and metastatic clones isolated from each neoplasm. In addition, we also examined nine somatic cell hybrids produced by the fusion of nonmetastatic and metastatic K-1735 clones. In the mouse melanoma, we found heterogeneity in nm23-1 steady-state expression levels among the clones and hybrids that did not correlate with their metastatic phenotype. Clones isolated from human colon or renal carcinomas expressed similar levels of nm23-HI regardless of metastatic potential in nude mice. All of the human tumor cells were heterozygous for the nm23-HI-specific allelic DNA fragments, with no allelic deletions or gross alterations detected. Since the failure of tumor cells to produce metastasis can be due to multiple deficiencies, these data stress the importance of using independent clones with different metastatic potentials for the analysis of gene regulation of this process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394207

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 2.  Nm23 and breast cancer metastasis.

Authors:  P S Steeg; A de la Rosa; U Flatow; N J MacDonald; M Benedict; A Leone
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  Integrin beta3 down-regulates invasive features of ovarian cancer cells in SKOV3 cell subclones.

Authors:  Jie Chen; Jie Zhang; Yaoran Zhao; Jun Li; Maosun Fu
Journal:  J Cancer Res Clin Oncol       Date:  2008-12-23       Impact factor: 4.553

4.  Domain mapping on the human metastasis regulator protein h-Prune reveals a C-terminal dimerization domain.

Authors:  Sabine Middelhaufe; Livia Garzia; Uta-Maria Ohndorf; Barbara Kachholz; Massimo Zollo; Clemens Steegborn
Journal:  Biochem J       Date:  2007-10-15       Impact factor: 3.857

Review 5.  Paracrine growth regulation of human colon carcinoma organ-specific metastasis.

Authors:  R Radinsky
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

6.  Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.

Authors:  K L van Golen; S Risin; A Staroselsky; D Berger; M A Tainsky; S Pathak; J E Price
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

7.  Expression of NM23 in human melanoma progression and metastasis.

Authors:  D J Easty; K Maung; I Lascu; M Véron; M E Fallowfield; I R Hart; D C Bennett
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

8.  Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.

Authors:  B R Henderson
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

9.  Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer.

Authors:  I Heide; C Thiede; K Poppe; E de Kant; D Huhn; C Rochlitz
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

10.  Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.

Authors:  J Watanabe; Y Sato; H Kuramoto; T Kameya
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.